Alveron Pharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.28M

  • Investors
  • 7

Alveron Pharma General Information

Description

Developer of a coagulation technology designed to create a cyclodextrin-based universal anticoagulant reversal drug. The company develops a ready-to-use injectable solution intended for the rapid reversal of anticoagulant or platelet inhibitor effects in patients with haemorrhagic stroke or intracranial haemorrhage, enabling medical practitioners to treat bleeding emergencies more quickly and effectively.

Contact Information

Website
www.alveron.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gasstraat 20
  • Kantoor 2.16
  • 5349 AA Oss
  • Netherlands
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Gasstraat 20
  • Kantoor 2.16
  • 5349 AA Oss
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alveron Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 06-Dec-2024 $5.28M Completed Clinical Trials - Phase 2
3. Early Stage VC 07-Oct-2021 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 16-May-2019 $7.28M $7.28M Completed Clinical Trials - Phase 1
1. Joint Venture 01-Mar-2019 Completed Startup
To view Alveron Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Alveron Pharma Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • Pending

  • Expiring in next 12 mo

Alveron Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017256640-A1 Cyclodextrins as procoagulants Active 29-Apr-2016
AU-2017256640-B2 Cyclodextrins as procoagulants Active 29-Apr-2016
CA-3022455-A1 Cyclodextrins as procoagulants Active 29-Apr-2016
CA-3022455-C Cyclodextrins as procoagulants Active 29-Apr-2016
EP-3448395-A1 Cyclodextrins as procoagulants Active 29-Apr-2016 A61K31/724
To view Alveron Pharma’s complete patent history, request access »

Alveron Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alveron Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Broadview Ventures Venture Capital Minority
Waterman Ventures Impact Investing Minority
Alumni Ventures Venture Capital Minority
Oost NL Venture Capital Minority
Thuja Capital Management Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Alveron Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Alveron Pharma Uk Grantham, United Kingdom 2019

Alveron Pharma FAQs

  • When was Alveron Pharma founded?

    Alveron Pharma was founded in 2019.

  • Where is Alveron Pharma headquartered?

    Alveron Pharma is headquartered in Oss, Netherlands.

  • What is the size of Alveron Pharma?

    Alveron Pharma has 7 total employees.

  • What industry is Alveron Pharma in?

    Alveron Pharma’s primary industry is Biotechnology.

  • Is Alveron Pharma a private or public company?

    Alveron Pharma is a Private company.

  • What is Alveron Pharma’s current revenue?

    The current revenue for Alveron Pharma is .

  • How much funding has Alveron Pharma raised over time?

    Alveron Pharma has raised $17.1M.

  • Who are Alveron Pharma’s investors?

    Broadview Ventures, Waterman Ventures, Alumni Ventures, Oost NL, and Thuja Capital Management are 5 of 7 investors who have invested in Alveron Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process